UK Approves Pfizer/BioNTech COVID-19 Vaccine for 12 to 15-Year-Olds

A 15-year-old receives the Pfizer-BioNTech vaccine against the CCP virus in Bloomfield Hills, Mich., on May 13, 2021. Jeff Kowalsky/AFP via Getty Images

Britain’s medicines regulator said on Friday that it has approved the use of the Pfizer/BioNTech CCP virus vaccine in 12 to 15-year-olds.

The Medicines and Healthcare products Regulatory Agency (MHRA) said the decision follows a “rigorous review” of safety and effectiveness in that age group.